Skip to main content
logo
QuadMedicine, Inc. (KOSDAQ:464490)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,170
-1,130 (-7.90%)
At close: Apr 2, 2026

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Biotechnology (Startups)
9.30B1.01B
Biotechnology (Startups) Growth
819.58%-
Total
9.30B1.01B
Total Growth
819.58%-

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
South Korea
8.46B1.01B
South Korea Growth
735.95%-
Europe
846.11M-
Total
9.30B1.01B
Total Growth
819.58%-
Source: S&P Global Market Intelligence.